Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SPRYthis companyARS Pharmaceuticals, Inc.	$2.85	-6.7×	10.05×	13.63×	-7.19×	-243.4%	75.8%	-212.9%	-203.3%	-149.9%	-62.2%	-14.9%	0.84×	-0.33×	-69.05×	7.28×	0.0%	2	-3.17	1	D+
AQSTAquestive Therapeutics, Inc.	$3.49	-8.5×	-23.41×	17.69×	-12.07×	-157.6%	61.5%	-156.4%	-188.1%	248.9%	-56.0%	-6.7%	-3.9×	-0.16×	-4.07×	3.14×	0.0%	3	-3.77	2	C
MNKDMannKind Corporation	$3.95	283.5×	-33.97×	4.97×	77.45×	-1108.3%	82.5%	11.1%	1.7%	-11.5%	5.8%	0.8%	-9.28×	14.48×	2.81×	1.7×	0.0%	1	-4.55	2	C+
XERSXeris Biopharma Holdings, Inc.	$15.35	2,242.86×	92×	4.32×	93.32×	-804.3%	81.7%	8.5%	0.2%	4.0%	8.9%	2.2%	2.76×	-5.77×	0.86×	2.19×	0.0%	5	1.35	2	C
Peer median	—	283.5×	-23.41×	4.97×	77.45×	-804.3%	81.7%	8.5%	0.2%	4.0%	5.8%	0.8%	-3.9×	-0.16×	0.86×	2.19×	0.0%	3	-3.77	2	—